XML 42 R25.htm IDEA: XBRL DOCUMENT v3.25.2
EQUITY TRANSACTIONS (Tables)
12 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of warrant activity
                
   Fiscal Year Ended March 31, 
   2025   2024 
   Warrants   Weighted
Average
Exercise Price
   Warrants   Weighted
Average
Exercise Price
 
Outstanding, beginning of year   4,090   $20.09    4,090   $20.09 
Granted   3,615,500   $3.58       $N/A 
Exercised   (1,231,305)  $3.92       $N/A 
Cancelled/Forfeited   (31,161)  $25.13       $N/A 
Outstanding, end of year   2,357,124   $3.55    4,090   $20.09 
Exercisable, end of year   2,357,124   $3.55    4,090   $20.09 
Weighted average estimated fair value of warrants granted       $N/A        $N/A 
Schedule of warrant activity exercisable and outstanding
                    
    Warrants Outstanding    Warrants Exercisable 
Range of
Exercise Prices
   Number
Outstanding
    Weighted
Average
Remaining
Life (Years)
    Weighted
Average
Exercise Price
    Number
Outstanding
    Weighted
Average
Exercise Price
 
$4.64 or Below   2,357,124    4.63   $3.55    2,357,124   $3.55 

 

The detail of the warrants outstanding and exercisable as of March 31, 2024 is as follows:

                     
   Warrants Outstanding   Warrants Exercisable 
Range of
Exercise Prices
  Number
Outstanding
   Weighted
Average
Remaining
Life (Years)
   Weighted
Average
Exercise Price
   Number
Outstanding
   Weighted
Average
Exercise Price
 
$150.00 or Below   2,531    0.71   $125.28    2,531   $125.28 
$200.00 - $220.00   1,559    0.81   $218.24    1,559   $218.24 
    4,090              4,090      
Schedule of options outstanding that have vested and are expected to vest
            
   Number of
Shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term in
Years
 
Vested   5,795   $132.82    6.02 
Expected to vest   751   $112.80    6.87 
Total   6,546           
Schedule of stock option activity
                
   Fiscal Year Ended March 31, 
   2025   2024 
   Options   Weighted
Average
Exercise Price
   Options   Weighted
Average
Exercise Price
 
Outstanding, beginning of year   10,816   $146.22    21,491   $180.93 
Granted      $       $ 
Cancelled/Forfeited   (4,270)  $170.29    (10,675)  $215.12 
Outstanding, end of year   6,546   $130.52    10,816   $146.22 
Exercisable, end of year   5,795   $132.82    7,236   $159.13 
Weighted average estimated fair value of options granted       $N/A        $N/A 
Schedule of nonvested shares
        
   Shares   Weighted Average Grant Date Fair Value 
Nonvested stock options at April 1, 2024   3,580   $120.13 
Vested   (1,628)  $138.95 
Forfeited   (1,201)  $99.19 
Nonvested stock options at March 31, 2025   751      
Schedule of detail of options outstanding and exercisable by exercise price
                    
   Options Outstanding   Options Exercisable 
Exercise Prices  Number
Outstanding
   Weighted
Average
Remaining
Life (Years)
   Weighted
Average
Exercise
Price
   Number
Outstanding
   Weighted
Average
Exercise
Price
 
$102.40-112.8   5,034    6.22 years   $109.17    4,283   $108.54 
$201.6   1,512    5.76 years   $201.60    1,512   $201.60 
Total   6,546              5,795      
Schedule of RSUs
    
   Shares 
Nonvested RSUs at April 1, 2024   611 
Granted   16,448 
Vested   (12,707)
Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units   (4,352)
Nonvested RSUs at March 31, 2025    
Schedule of stock-based compensation
        
   Fiscal Year Ended 
   March 31, 2025   March 31, 2024 
Vesting of restricted stock units  $218,750   $206,250 
Vesting of stock options   196,484    1,013,120 
Total Stock-Based Compensation  $415,234   $1,219,370